News Conference News ACC 2019 REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events Yael L. Maxwell March 22, 2019
News Daily News No Free Brunch? Eggs Once Again Feel the Scramble in New, Large Observational Study Caitlin E. Cox March 22, 2019
News Conference News Flu Vaccination Tied to Less MI in Hospitalized Patients Todd Neale March 13, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Daily News Updated AHA Scientific Statement Addresses CV Risk Reduction in High-Risk Youth Todd Neale March 05, 2019
News Daily News ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD Michael O'Riordan March 01, 2019
News Daily News Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics Caitlin E. Cox February 27, 2019
News Daily News CT Angiography Bests Functional Testing in Diabetic Patients With Chest Pain: PROMISE Michael O'Riordan February 25, 2019
News Daily News Breast Calcifications May Hold Important Clues for CV Risk Stratification L.A. McKeown February 22, 2019
News Daily News Call to Action Issued for CVD Care in Female Military Veterans Todd Neale February 21, 2019
News Daily News Long Bouts of Sedentary Time Linked to CVD Risk in Women Michael O'Riordan February 20, 2019
News Daily News Atherosclerosis Features Differ Among Male Athletes From Different Sports Todd Neale February 18, 2019
News Daily News Human Papilloma Virus May Contribute to CVD Risk in Women, Korean Study Finds L.A. McKeown February 08, 2019
News Daily News Age Shouldn’t Be a Barrier to Statin Therapy, Meta-analysis Suggests Michael O'Riordan February 08, 2019
News Daily News One in Two Americans Have Cardiovascular Disease: AHA Stats Michael O'Riordan February 04, 2019
News Daily News EuroCTO CASTLE: Prediction Model for CTO PCI Success Shows Good Discriminating Ability L.A. McKeown February 04, 2019
News Features Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis? Michael O'Riordan February 01, 2019